Corbus Pharmaceuticals Holdings Inc CRBP
$10.38 $0.54 (5.49%) 1D
Last Updated: Aug 21, 12:00 AM·NASDAQ
Pricing for US stocks is delayed by 24 hours
CRBP Shariah Compliance
Screening Methodology: AAOIFI
As of August 2026, Corbus Pharmaceuticals Holdings Inc is classified as not halal.
NOT HALAL
Report Source: undefined Quarter Report
Corbus Pharmaceuticals Holdings Inc. Stock Analysis CRBP
United States Health Care Micro Cap Corbus Pharmaceuticals Holdings, Inc. is an oncology company, which engages in research, development, and commercializing therapeutics for cancer and obesity. The company is headquartered in Norwood, Massachusetts and currently employs 36 full-time employees. The company went IPO on 2014-10-24. The firm has a diversified portfolio and is committed to helping people defeat serious illness by bringing scientific approaches to well-understood biological pathways. The Company’s oncology pipeline comprises two experimental drugs targeting solid tumors: CRB-701, an antibody drug conjugate (ADC) that targets the expression of Nectin-4 on cancer cells to release a cytotoxic payload, and CRB-601, an anti-integrin monoclonal antibody that blocks the activation of TGFB expressed on cancer cells. CRB-701 is a monoclonal antibody attached to a monomethyl auristatin E (MMAE) cytotoxic payload using a proprietary linker technology. The pipeline also includes CRB-913, a highly peripherally restricted cannabinoid type-1 (CB1) receptor inverse agonist for the treatment of obesity. CB1 inverse agonism is a clinically validated mechanism to induce weight loss.
Corbus Pharmaceuticals Holdings Inc (CRBP) Chart
Financial Metrics & Statements of Corbus Pharmaceuticals Holdings Inc (CRBP)
FAQ's for Corbus Pharmaceuticals Holdings Inc (CRBP)
- As of August 2026, Corbus Pharmaceuticals Holdings Inc CRBP is classified as not halal according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.
- A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Corbus Pharmaceuticals Holdings Inc using these criteria to determine its compliance status.
- Muslim investors may consider investing in Corbus Pharmaceuticals Holdings Inc if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
- Musaffa determines the Shariah status of Corbus Pharmaceuticals Holdings Inc by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
- The Shariah compliance status of Corbus Pharmaceuticals Holdings Inc may be updated periodically when new financial statements, earnings reports, or business activity information become available.
- Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
- You can check the latest Shariah compliance status of Corbus Pharmaceuticals Holdings Inc on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.
Alternate Halal Stocks for Corbus Pharmaceuticals Holdings Inc (CRBP)
Related Halal Stocks are Shariah-compliant companies that align with Islamic investment principles, avoiding prohibited industries like alcohol, gambling, and interest-based finance.
